1
|
Oliveira Bekkers E, Ducoutumany G, Tran Luy M, Airagnes G, Limosin F, Le Faou AL. [Smoking behaviours among staff of two university hospitals in Paris, 2021]. Rev Mal Respir 2022; 39:212-220. [PMID: 35210125 DOI: 10.1016/j.rmr.2021.12.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Accepted: 12/21/2021] [Indexed: 10/19/2022]
Abstract
INTRODUCTION A survey on smoking prevalence was conducted among staff at the Georges Pompidou and Corentin Celton hospitals in the framework of the "smoke-free hospital" project. It aimed to determine the smoking status of different categories of personnel, their desire to be helped to quit and, as regards healthcare staff, whether or not they were encouraging patients who smoked to try to quit. METHODS From February to May 2021, an anonymous survey was distributed, first on paper in the occupational health unit, and then online in all wards. RESULTS All in all, 775 people, three quarters of whom were women, participated in the survey (15% of the workforce). Among the respondents, 27% said they smoked: 29.6% of the men and 26.1% of the women. Unsurprisingly, the age group with the highest prevalence was 18-24years. High prevalence was likewise found among technical and administrative staff. More than half of the smokers, who consumed an average of 8 cigarettes a day, were interested in receiving smoking cessation support. As regards smoking cessation support for patients, 49% of medical and nursing staff (70% of the doctors) frequently or systematically advised them to quit. CONCLUSION Our results illustrate a need to reach high-prevalence categories of smokers in a hospital setting, the objective being to help them to consider quitting, and also a need to train health professionals in smoking cessation counseling.
Collapse
Affiliation(s)
- E Oliveira Bekkers
- DMU psychiatrie et addictologie, AP-HP, centre-Université de Paris, Paris, France.
| | - G Ducoutumany
- DMU psychiatrie et addictologie, AP-HP, centre-Université de Paris, Paris, France
| | - M Tran Luy
- DMU psychiatrie et addictologie, AP-HP, centre-Université de Paris, Paris, France
| | - G Airagnes
- DMU psychiatrie et addictologie, AP-HP, centre-Université de Paris, Paris, France; Population-based Epidemiological Cohorts Unit, INSERM UMS 11, Villejuif, France
| | - F Limosin
- DMU psychiatrie et addictologie, AP-HP, centre-Université de Paris, Paris, France; Centre psychiatrie et neurosciences, U894, Inserm, Paris, France
| | - A-L Le Faou
- DMU psychiatrie et addictologie, AP-HP, centre-Université de Paris, Paris, France
| |
Collapse
|
2
|
Capelle A, Obadia JF, Iung B, Messika-Zeitoun D, Vahanian A, Guerin P, Lefèvre T, Bonnet G, Donal E, Leurent G, Trochu JN, Armoiry X. Percutaneous mitral valve repair in severe secondary mitral regurgitation: Analysis of index hospitalization and economic evaluation based on the MITRA-FR trial. Arch Cardiovasc Dis 2021; 114:805-13. [PMID: 34802961 DOI: 10.1016/j.acvd.2021.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Revised: 06/30/2021] [Accepted: 10/21/2021] [Indexed: 11/21/2022]
Abstract
BACKGROUND Percutaneous mitral valve repair (pMVR) is reimbursed in France for severe secondary mitral regurgitation (SMR), but French data regarding the hospitalization index stay are lacking. AIMS Our objectives were to describe the index hospitalization stay and to evaluate the cost of hospital stay for pMVR used in SMR. METHODS A secondary evaluation based on patients who were randomized to the intervention group of the MITRA-FR study was undertaken. The economic evaluation was conducted according to the French hospital perspective. Medical resource use was estimated using specific data collected from patients enrolled in the MITRA-FR study and non-specific data from national statistics. RESULTS The population was represented by 144 patients who underwent pMVR at 33 French centres. There was a mean±standard deviation of 7.9±1.5 hospital staff during procedures. The mean procedure duration was 154±68 minutes and increased with the number of implanted clips. Median total length of stay was 8 days. The occurrence of a serious adverse event was not associated with an increased risk of admission to the critical care unit, but was associated with an increased length of stay. The mean total cost was 28,025±3424€, which includes 21,547€ for the cost of medical devices used during pMVR and 6478±3424€ for other costs. CONCLUSION The cost of pMVR is substantial for patients with SMR, which advocates for further efforts to identify the patients with SMR who are likely to derive a clear clinical benefit from the procedure.
Collapse
|
3
|
Tanty A, Dantigny R, Bardet JD, Chanoine S, Bedouch P, Allenet B. [French hospital clinical pharmacy: an identity crisis?]. Ann Pharm Fr 2021; 79:431-9. [PMID: 33309602 DOI: 10.1016/j.pharma.2020.11.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2020] [Revised: 11/23/2020] [Accepted: 11/26/2020] [Indexed: 11/24/2022]
|
4
|
Bawe LD, Kotosso A, Nemi KD, Abaltou B, Moukaïla AR, Blatome T, N'Djao A, Patassi AA, M I W. [Prevalence and Management of Snake Bite Envenomation at the Regional Hospital Center of Sokodé (Togo)]. ACTA ACUST UNITED AC 2020; 113:215-221. [PMID: 33826271 DOI: 10.3166/bspe-2020-0145] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Accepted: 11/23/2020] [Indexed: 11/20/2022]
Abstract
Snakebite envenomation (SBE) is a public health issue in Africa, unfortunately neglected and underestimated. SBE is a medical emergency that can be devastating and lifethreatening. A retrospective study was performed from January 1, 2016 to December 31, 2016 in the general medicine department of the Regional Hospital Center (CHR), Sokodé. We included 91 SBE accounting for 5.7% of the whole hospitalizations in the general medicine department at the CHR of Sokodé. The median age of the patients was 34 [23.5-42] with male predominance (59%). Farming activities (75%) and walking (24%) were the most frequent activities when SBE happened, and they occurred mostly in rural areas (80%) during the dry season (56%). Echis genus (37%) belonging to the Viperidae family was the king of snake most often identified. Hospital admission time after a bite often exceeded 24 hours (44%). Clinical manifestations resulted in 76 cases of viper syndrome (83%) and 7 cases of dry bites (8%). Antivenom was administered in 84 cases (92%) within 12 hours (54%) after the bite with a minimum dose of 20 mL (43%). Observed complications were severe anemia (19 cases) and diffuse hemorrhage (32 cases). Case fatality rate was 9%. Antivenom is critical in cases of obvious SBE. High cost and poor access of antivenom, in addition to delayed care due to traditional treatment seeking behavior, are factors of poor prognosis.
Collapse
Affiliation(s)
- L D Bawe
- Service de médecine générale, CHR de Sokodé, Togo
| | - A Kotosso
- Centre hospitalier des Armées de Lomé, Togo
| | - K D Nemi
- Service de médecine interne, CHU Sylvanus-Olympio, Lomé, Togo
| | - B Abaltou
- Service des maladies infectieuses, CHU Sylvanus-Olympio, Lomé, Togo
| | - A R Moukaïla
- Hopital de jour, service des maladies infectieuses CHU Sylvanus Olympio Lomé, Togo
| | - T Blatome
- Centre africain de recherche en santé publique, 89, rue des Sarrasins, BP 4089, Lomé, Togo
| | - A N'Djao
- Service de médecine générale, CHR de Sokodé, Togo
| | - A A Patassi
- Service des maladies infectieuses, CHU Sylvanus-Olympio, Lomé, Togo
| | - Wateba M I
- Service des maladies infectieuses, CHU Sylvanus-Olympio, Lomé, Togo
| |
Collapse
|
5
|
Mabiala-Babela JR, Nika ER, Ikobo LCO, Gnakingue ANO, Ngoulou BPS, Mandilou SVM. [Homozygous Sickle Cell Children Treated with Hydroxyurea in Brazzaville (Congo)]. ACTA ACUST UNITED AC 2020; 112:206-212. [PMID: 32003197 DOI: 10.3166/bspe-2019-0096] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2019] [Accepted: 10/31/2019] [Indexed: 11/20/2022]
Abstract
The objective of this study is to reduce the morbidity of children with homozygous sickle cell disease presenting severe forms. We have conducted a longitudinal study between November 2015 and September 2017 at the Brazzaville University Hospital. Children with sickle cell disease requiring treatment with hydroxyurea were included. The variables studied were therapeutic compliance, evolutive profile of nutritional status, indications of hydroxyurea, electrophoresis of hemoglobin, blood count, and toxicity. The statistical test used was Student test with a significance threshold of less than 0.05. One thousand twenty-four children were monitored for sickle cell disease, 107 of which had received hydroxyurea (10.4%). The indications for hydroxyurea were recurrent anemic attacks (≥ 4) in 62 cases (57.9%), neurological crises 19 cases (17.8%), recurrent hyperalgesic crises in 17 cases (15.9%), priapism in 4 cases (3.7), and acute thoracic syndrome in 2 cases (1.9%). Therapeutic compliance was good in 89.5% of them. A rapid and lasting clinical improvement was noted in the majority of patients with hyperalgesic attacks (88.2%) and anemic attacks (88.7%), two recurrences for the cerebrovascular accidents, and an absence of recurrence of priapism and of the acute thoracic syndrome. From the biological point of view, there was a significant increase in fetal hemoglobin (1.2 to 16.2%; P < 0.05), hemoglobin (7 to 8.3 g/dl; P < 0.05), mean cell volume (80.8 to 96 fl; P < 0.05) and a significant decrease in mean white blood cell count (15,633 to 9,872/mm3; P < 0.05) and platelets (387,002 to 324,400/mm3; P < 0.05). The signs of toxicity observed were mainly vomiting and thrombocytopenia in two cases each, one case with headache and the other with neutropenia. Indications for use of hydroxyurea therapy in children with sickle cell disease in Brazzaville are common. These are dominated by recurrent anemic seizures, strokes, and hyperalgesic seizures. The excellent evolution of these complications under hydroxyurea represents an interesting alternative in our countries with limited resources.
Collapse
Affiliation(s)
- J R Mabiala-Babela
- Faculté des sciences de la santé, université Marien-Ngouabi, Brazzaville, Congo.,Service de pédiatrie nourrisson, CHU de Brazzaville, Brazzaville, Congo
| | - E R Nika
- Service de pédiatrie nourrisson, CHU de Brazzaville, Brazzaville, Congo
| | - L C Ollandzobo Ikobo
- Faculté des sciences de la santé, université Marien-Ngouabi, Brazzaville, Congo.,Service de pédiatrie nourrisson, CHU de Brazzaville, Brazzaville, Congo
| | | | - B P S Ngoulou
- Service de pédiatrie nourrisson, CHU de Brazzaville, Brazzaville, Congo
| | | |
Collapse
|
6
|
Niamkey JT, Yao H, Traoré F, Ekou A, Angoran I, Koffi DNB, Kadio M, Anzouan-Kacou JB. [Assessment of Contraindications to Percutaneous Mitral Commissurotomy (PMC) in Abidjan Heart Institute, Côte d'Ivoire]. ACTA ACUST UNITED AC 2020; 112:187-189. [PMID: 32003193 DOI: 10.3166/bspe-2019-0102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2019] [Accepted: 12/09/2019] [Indexed: 11/20/2022]
Abstract
Rheumatic mitral stenosis is still common in sub-Saharan Africa. The aim of this study was to evaluate the clinical and echocardiographic contraindications to the realization of percutaneous mitral commissurotomy (PMC) in Abidjan Heart Institute. We conducted a prospective, transversal and analytical study in the Exploration Unit from March 30, 2017 to March 30, 2018. Mitral stenosis was severe with an average anatomical surface area of 0.87cm2, an average gradient of 13.7 mmHg and an upstream repercussion (dilatation of the left atrium (78 ml/m2); moderate dilatation of the right atrium (22.3 cm2) and average pulmonary arterial hypertension (PAH) of 55 mmHg). The main clinical contraindications were a history of rest dyspnoea at 66.7%, permanent atrial fibrillation at 53.3 % and clinical manifestations of severe PAH in 40 %. Unfavourable anatomy (95.7 %) evaluated by scores of Wilkins, Cormier and especially Echoscore revisited; bicommissural fusion (95.7 %) and severe aortic valvulopathy (31.1%) were the main barriers in transthoracic echocardiography. In multivariate analysis after linear regression, valvular anatomy, as assessed by the various scores, was significantly related to low socioeconomic status (p=0.018), level of education (p=0.04), severity of mitral stenosis evaluated by the mean gradient (p=0.033) and the impact on the left atrium (p=0.015). Mitral stenosis presents several clinical and echocardiographic contraindications. Adverse anatomy is the main obstacle and is related to low socio-economic status, educational level and severity of stenosis.
Collapse
Affiliation(s)
- J T Niamkey
- Service des explorations externes de l'Institut de cardiologie d'Abidjan, BPV 206 Abidjan, Côte d'Ivoire
| | - H Yao
- Service des soins intensifs de l'Institut de cardiologie d'Abidjan BPV 206 Abidjan, Côte d'Ivoire
| | - F Traoré
- Service des explorations externes de l'Institut de cardiologie d'Abidjan, BPV 206 Abidjan, Côte d'Ivoire
| | - A Ekou
- Service des soins intensifs de l'Institut de cardiologie d'Abidjan BPV 206 Abidjan, Côte d'Ivoire
| | - I Angoran
- Service des explorations externes de l'Institut de cardiologie d'Abidjan, BPV 206 Abidjan, Côte d'Ivoire
| | - D N B Koffi
- Service des explorations externes de l'Institut de cardiologie d'Abidjan, BPV 206 Abidjan, Côte d'Ivoire
| | - M Kadio
- Service des explorations externes de l'Institut de cardiologie d'Abidjan, BPV 206 Abidjan, Côte d'Ivoire
| | - J B Anzouan-Kacou
- Service des explorations externes de l'Institut de cardiologie d'Abidjan, BPV 206 Abidjan, Côte d'Ivoire
| |
Collapse
|
7
|
Sarr L, Dembélé B, Limam M, Daffé M, Diouf AB, Gueye AB, Diao S, Diop M, Coulibaly NF, Diémé C. [Recidives of Mycetoma after Amputation in Dakar (Senegal)]. ACTA ACUST UNITED AC 2020; 112:195-201. [PMID: 32003194 DOI: 10.3166/bspe-2019-0103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2019] [Accepted: 12/12/2019] [Indexed: 11/20/2022]
Abstract
The treatment of fungal mycetoma is essentially surgical. This carcinological-like surgery consists of amputation in case of bone involvement. The recurrences after amputation are rare and address the problem of the operative indication. We report 5 cases of recurrence of fungal black-grain mycetoma after amputation of leg or thigh. Case 1: a 52-year-old patient with a mycetoma of the knee evolving for 8 years. There is no history of surgery. A thigh amputation with ganglion dissection is performed. One year after the surgical procedure, the patient presents a recurrence on the amputation stump and on the lymph node dissection site. An indication of hip disarticulation is made and performed 17 months after amputation. Case 2: a 25-year-old patient who has a black-grain mycetoma of the foot with osteitis evolving since 10 years. A leg amputation was performed. The patient had a recurrence at the popliteal level at 15 months postoperatively. An indication of amputation of the thigh is posed and refused by the patient. Case 3: a30-year-old woman with black-grain mycetoma of the knee with bone involvement for more than 10 years. A thigh amputation was performed and at nine months postoperativeshe presented a recurrence in the amputation stump. She was lost of sight despite the decision of surgical revision. Case 4: a 43-year-old patient operated on his foot and leg mycetoma at least 5 timesbefore amputation in 2000. The recurrence occurred one year after amputation. 18 years after amputation, a new surgical procedure was difficult due to extension of the lesions in the pelvis. Case 5: a 50-year-old female patient operated in Mauritania in 2012 (thigh amputation for mycetoma of the knee). She presented a recurrence on the amputation stump in 2018. An indication of disarticulation of the hip was posed and refused by the patient. These recurrences were testified by to the persistence of grains on the preserved segment. They pose the problem of the level of amputation and therefore of preoperative planning. Good preoperative planning allows optimization of the surgical procedure and avoids certain recurrences.
Collapse
Affiliation(s)
- L Sarr
- Service orthopédie-traumatologie, Hôpital Aristide Le Dantec, Dakar, Sénégal
| | - B Dembélé
- Service orthopédie-traumatologie, Hôpital Aristide Le Dantec, Dakar, Sénégal
| | - M Limam
- Service d'orthopédie-traumatologie, Hôpital Cheikh Zayed, Nouakchott, Mauritanie
| | - M Daffé
- Service orthopédie-traumatologie, Hôpital Aristide Le Dantec, Dakar, Sénégal
| | - A B Diouf
- Service orthopédie-traumatologie, Hôpital Aristide Le Dantec, Dakar, Sénégal
| | - A B Gueye
- Centre hospitalier de l'Ordre de Malte, Dakar, Sénégal
| | - S Diao
- Service orthopédie-traumatologie, Hôpital Général de Grand Yoff, Dakar, Sénégal
| | - M Diop
- Service orthopédie-traumatologie, Hôpital Aristide Le Dantec, Dakar, Sénégal
| | - N F Coulibaly
- Service orthopédie-traumatologie, Hôpital Aristide Le Dantec, Dakar, Sénégal
| | - C Diémé
- Service orthopédie-traumatologie, Hôpital Aristide Le Dantec, Dakar, Sénégal
| |
Collapse
|
8
|
Traoré C, Kyelem CG, Semdé A, Koulidiati J, Sanou AF, Bokoum S, Kafando E. [Prevalence of Chronic Complications of Sickle Cell Disease at the Bobo-Dioulasso Teaching Hospital, Burkina Faso]. ACTA ACUST UNITED AC 2020; 113:5-11. [PMID: 32881448 DOI: 10.3166/bspe-2020-0112] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2019] [Accepted: 03/18/2020] [Indexed: 11/20/2022]
Abstract
This is a descriptive cross-sectional unicentric study, with a prospective collection of data on the frequency of chronic complications of sickle cell disease in patients monitored at Souro Sanou University Hospital in Bobo-Dioulasso in the department of medicine conducted from April 1, 2017 to July 31, 2018. Patients with confirmed adult sickle cell disease, at least 16 years of age, who had given oral consent, was seen at least twice in the inter-critical period during the study, and who had performed a biological and / or radiological screening for chronic complications. Out of 144 sickle cell patients seen, 79 met our inclusion criteria. The mean age of the patients was 28.8 ± 10.3 years with extremes of 16 and 63 years. Females predominated in 68% of cases (N = 54). Sickle cells were of SC phenotype in 68% of cases, SS in 24%, Sβ + in 5% of cases and Sβ0 in 3% of cases. The overall prevalence of complications was 54% (43/79), 68% (13/19) in SS individuals and 50% in SC individuals (27/54). The observed chronic complications were ocular, bony, renal, cardiac, cutaneous respectively in 19%, 13%, 6.3%, 5% and 4% of cases, biliary and neurological in 3% each, ENT and pulmonary in 1.3% each. The mean age of patients with at least one chronic complication was 30.9 ± 10.4 years; it was 32.1 ± 10.3 years old in the SC and 25.3 ± 7.8 years old in the SS. Complications were unique in 72%, double in 23% and triple in 5%. The prevalence of chronic complications of sickle cell disease is high in patients with major sickle cell syndrome. Systematic screening and evaluation of organ damage are required to interrupt or delay their evolution.
Collapse
Affiliation(s)
- C Traoré
- CHU Sourô-Sanou de Bobo-Dioulasso, 03, BP4178, Burkina Faso
| | - C G Kyelem
- CHU Sourô-Sanou de Bobo-Dioulasso, 03, BP4178, Burkina Faso
| | - A Semdé
- CHU Sourô-Sanou de Bobo-Dioulasso, 03, BP4178, Burkina Faso
| | - J Koulidiati
- CHU Yalgado-Ouédraogo, Ouagadougou, Burkina Faso
| | - A F Sanou
- CHU de Bogodogo, Ouagadougou, Burkina Faso
| | - S Bokoum
- CHU Sourô-Sanou de Bobo-Dioulasso, 03, BP4178, Burkina Faso
| | - E Kafando
- CHU Charles-De-Gaulle, Ouagadougou, Burkina Faso
| |
Collapse
|
9
|
Tran Luy M, Le Faou AL, Airagnes G, Limosin F. [Systematic identification of smokers and tobacco smoking management in the general hospital]. Rev Mal Respir 2020; 37:644-651. [PMID: 32883549 DOI: 10.1016/j.rmr.2020.06.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2020] [Accepted: 06/30/2020] [Indexed: 11/26/2022]
Abstract
INTRODUCTION The prevalence of daily smoking in France was 24 % in 2019 and tobacco control remains a major public health issue. A hospital stay provides an opportunity for smoking cessation intervention. Identification and management of smokers during a hospital stay may be variously integrated into electronic health records (EHR). STATE OF THE ART Smoking status identification, which have included pre-filled forms, check-box, reminders, icons, is heterogeneous. Specific modules in EHR have been implemented for smoking cessation management such as counselling sessions, tobacco cessation prescriptions, smoking cessation guidelines and long-term follow-up. EHR-based intervention to identify and manage smokers with a long-term follow-up for at least one month after hospital discharge has shown an increase in smoking abstinence at 6-12 months. OUTLOOK Due to the lower quality of free data about smoking status, systematic identification with check-box, reminders or icons in EHR may be more appropriate. Integration of functionalities such as help for prescription, reminders and follow-up of patients would make tobacco cessation management easier for health professionals. CONCLUSION EHR interventions to identify smokers and manage smoking cessation during hospital stays are an opportunity to increase smoking cessation.
Collapse
Affiliation(s)
- M Tran Luy
- DMU psychiatrie et addictologie, Centre-Université de Paris, AP-HP, France.
| | - A-L Le Faou
- DMU psychiatrie et addictologie, Centre-Université de Paris, AP-HP, France
| | - G Airagnes
- DMU psychiatrie et addictologie, Centre-Université de Paris, AP-HP, France; Population-based epidemiologic Cohorts, UMS 011, inserm, France
| | - F Limosin
- DMU psychiatrie et addictologie, Centre-Université de Paris, AP-HP, France; Centre psychiatrie et neurosciences, U894, inserm, France
| |
Collapse
|
10
|
Sarr SA, Aw F, Ndiaye M, Mingou J, Bodian M, Dioum M, Ngaidé AA, Ndiaye MB, Kane A, Diao M, Ba SA. [Chronic Right Ventricular Failure Revealing a Large Compressive Hydatid Cyst at the Cardiology Department of the Aristide le Dantec Hospital (Dakar, Senegal)]. ACTA ACUST UNITED AC 2020; 112:202-205. [PMID: 32003192 DOI: 10.3166/bspe-2019-0090] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2019] [Accepted: 10/29/2019] [Indexed: 11/20/2022]
Abstract
Hydatidosis, an anthropozoonosis caused by the development of the Echinococcus granulosus larva in human, is a parasitic infection that is endemic in many countries. Pericardial localization in the absence of other cardiac involvement is extremely rare. Its spontaneous evolution is serious because of the risk of rupture. We report the case of a 65-year-old patient, who received limb edema that had been going on for 4 months, and in whom the physical examination noted a 3/6 tricuspid regurgitation and a right heart failure syndrome. Transthoracic echocardiography revealed an intra-pericardial mass whose contents appeared fluid with hyperechogenic area. It measured 86x61 mm and significantly compressed the straight cavities. Thoracic computed tomography showed an appearance in favor of an aged intrapericardic hydatid cyst (GHARBI V) with mass effect on the right cavities. The hydatid serology was negative. The patient did not accept the surgical cure. She had been put on albendazole and diuretic treatment. Fatal outcome was reported after two-month follow-up.
Collapse
Affiliation(s)
- S A Sarr
- Service de cardiologie du Centre hospitalier universitaire Aristide Le Dantec, Dakar, Sénégal
| | - F Aw
- Service de cardiologie du Centre hospitalier universitaire Aristide Le Dantec, Dakar, Sénégal
| | - M Ndiaye
- Service de cardiologie du Centre hospitalier universitaire Aristide Le Dantec, Dakar, Sénégal
| | - J Mingou
- Service de cardiologie du Centre hospitalier universitaire Aristide Le Dantec, Dakar, Sénégal
| | - M Bodian
- Service de cardiologie du Centre hospitalier universitaire Aristide Le Dantec, Dakar, Sénégal
| | - M Dioum
- Service de cardiologie du Centre hospitalier national de Fann, Dakar, Sénégal
| | - A Alassane Ngaidé
- Service de cardiologie du Centre hospitalier national de Grand Yoff, Dakar, Sénégal
| | - M Bamba Ndiaye
- Service de cardiologie du Centre hospitalier universitaire Aristide Le Dantec, Dakar, Sénégal
| | - A Kane
- Service de cardiologie du Centre hospitalier universitaire Aristide Le Dantec, Dakar, Sénégal
| | - M Diao
- Service de cardiologie du Centre hospitalier universitaire Aristide Le Dantec, Dakar, Sénégal
| | - S Abdou Ba
- Service de cardiologie du Centre hospitalier universitaire Aristide Le Dantec, Dakar, Sénégal
| |
Collapse
|
11
|
Ikobo LCO, Mberi FDM, Nika ER, Mandilou SVM, Ngoulou BSA, Loufoua ABM, Mabiala-Babela JR. [Evaluation of the Follow-Up and State of Adolescents with Sickle-Cell Disease in Brazzaville (Congo)]. ACTA ACUST UNITED AC 2020; 112:213-219. [PMID: 32003198 DOI: 10.3166/bspe-2019-0097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2019] [Accepted: 10/31/2019] [Indexed: 11/20/2022]
Abstract
The experience of the adolescent with homozygous sickle-cell disease is influenced by several factors that differentiate it from the older child entirely dependent on his parents. The objective of this study was to describe the state of health and to assess the quality of follow-up and to identify the determinants of poor monitoring of adolescent sickle-cell followed in Brazzaville for an average of 12 ± 9.6 years, starting from a cross-sectional study carried out at the Brazzaville University Hospital from March to September 2016. It is based on a questionnaire composed of elements of assessment of the state of health and the quality of the follow-up. The vaccination coverage of adolescents was low, 81.3% for DTCP, 66.5% for Typhim Vi, 50.2% for viral hepatitis B, 76.4% for pneumococcus, and 59.1% for the ROR. In the last two years prior to the survey, 99 (48.7%) adolescents had only 2 follow-up visits instead of 4 planned per year. Therapeutic compliance was good in 132 (65%). No hospitalizations were reported during this period in 23 adolescents (11.3%); in 180 cases (88.7%), however, adolescents were hospitalized one to three times apart from regular follow-up visits. Since the discovery of the disease, 177 (87.2%) adolescents had already been transfused, more than three times in 89 cases. A history of neurovascular seizures was found in 10 cases (5.2%) and priapism in 35 cases (18.2%). Paraclinical examinations were not systematic during follow-up visits. The socioeconomic level of the family and the level of education of the father had a negative impact on monitoring and adherence (P < 0.01). On clinical examinations, stunting, undernutrition, pubertal delay, tooth decay, enuresis were found in 45.3%, 36%, 53.7%, 27.6%, 15.3%, respectively. The biological examinations carried out during the investigation showed an average inter-critical hemoglobin level between 7 and 8 g/dl, creatinine level was normal in all cases, ferritinemia was elevated in 93.6%, a negative proteinuria was found in 71.4% of the cases, and hematuria in 26.6%. Systematic abdominal ultrasound revealed vesicular lithiasis in 8 cases, hepatomegaly in 10 cases, and splenomegaly in 102 cases. Echocardiography performed in all subjects showed cardiomyopathy in 9 cases. The follow-up of the adolescent sickle-cell in Brazzaville still faces enormous difficulties. The improvement of the standard of living, the therapeutic education and the introduction of a total free of charge of the global management of sickle-cell disease would make it possible to minimize these difficulties which also would improve the future of these teenagers, adults of tomorrow.
Collapse
Affiliation(s)
- L C Ollandzobo Ikobo
- Faculté des sciences de la santé, université Marien-Ngouabi de Brazzaville, Congo.,Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo
| | - F D Mouyabi Mberi
- Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo
| | - E R Nika
- Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo
| | - S V Missambou Mandilou
- Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo
| | - B S A Ngoulou
- Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo
| | - A B M'Pemba Loufoua
- Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo
| | - J R Mabiala-Babela
- Faculté des sciences de la santé, université Marien-Ngouabi de Brazzaville, Congo.,Service de pédiatrie-nourrissons, centre hospitalier et universitaire de Brazzaville, Congo
| |
Collapse
|
12
|
Ibrahim Mamadou AK, Harouna Amadou ML, Toudou Daouda M, Hama Aghali N, Abdoulaye O, Moussa I. [Clinical and Therapeutic Profile and Outcomes of Patients with Tuberculosis at the Regional Hospital of Tahoua, Republic of the Niger]. Bull Soc Pathol Exot 2020; 113:263-267. [PMID: 33881253 DOI: 10.3166/bspe-2020-0153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
This study aims to describe the epidemiological, clinical, therapeutic characteristics of patients followed for tuberculosis at the Regional Hospital Center of Tahoua (Niger) as well as their outcomes.We conducted a retrospective and descriptive study from the medical records of patients followed for tuberculosis between January 1, 2017 and December 31, 2019. A total of 465 patients were included in the present study (304 men and 161 women; mean age: 30 years). Patients coming from urban areas represented 51% of the cases. Bacteriologically confirmed pulmonary tuberculosis represented 63% of the cases, 15% of clinically diagnosed pulmonary tuberculosis and 22% of extrapulmonary tuberculosis including Pott's disease. The HIV testing rate was 97.8%. Tuberculosis-HIV association represented 13% of the cases. The therapeutic success was 90.5%. The lethality rate was 5.2% (24/465). Among 24 patients who died, three had tuberculosis-HIV association.
Collapse
Affiliation(s)
- A K Ibrahim Mamadou
- Service de médecine et spécialités médicales, centre hospitalier régional de Tahoua, Tahoua, Niger
| | - M L Harouna Amadou
- Service d'infectiologie, hôpital régional de Maradi, faculté des sciences de la santé de l'université de Maradi, Maradi, Niger
| | - M Toudou Daouda
- Service de neurologie, hôpital national de Niamey, Niamey, Niger
| | - N Hama Aghali
- Service de biologie, hôpital régional de Maradi, faculté des sciences de la santé de l'université de Maradi, Maradi, Niger
| | - O Abdoulaye
- Service de biologie, hôpital régional de Maradi, faculté des sciences de la santé de l'université de Maradi, Maradi, Niger
| | - I Moussa
- Service de biologie, hôpital régional de Maradi, Maradi, Niger
| |
Collapse
|
13
|
Kpossou AR, Gbessi DG, Gnangnon FHR, Kanhonou KDCE, Sokpon CNM, Vignon RK, Séidou F, Séhonou J. [Epidemiology of primitive digestive cancers in adult in three specialized health centers in Cotonou (Benin Republic)]. ACTA ACUST UNITED AC 2020; 113:254-257. [PMID: 33881252 DOI: 10.3166/bspe-2020-0152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Health research studies are increasingly focusing on digestive cancers because of their increasing frequency and severity. The objective of this work was to study the epidemiological aspects of primary digestive cancers in adults in three hospital centers in the commune of Cotonou. A total of 676 cases of digestive cancers were identified out of 25,093 patients received during the study period (2.7%). The mean age was 54 ± 14.1 years: [16-96] and the sex ratio was 2:1. The most frequent cancers were those of the liver (259; 38.3%) and colon-rectum (154; 22.8%). The next most common cancers in descending order were gastric cancer (12%), esophageal cancer (11.4%), pancreatic cancer (11.4%), anal cancer (1.9%), hail cancer (1.5%) and biliary cancer (0.7%). The average time to visit was 9 months. The main risk factors found were viral hepatitis B and C, alcoholism, diabetes, obesity, colonic polyps, smoking, excessive consumption of salt and dietary nitrates. Lethality was 58.4%, with cancers of the liver, colon-rectum, pancreas, and esophagus in descending order of mortality. The average overall survival was 10 months. Digestive cancers most often affect people in their fifties, who are usually men in Cotonou. They are dominated by liver cancer and colorectal cancer. Modifiable risk factors are often found. The control of these factors and early diagnosis could help improve the survival of patients affected.
Collapse
Affiliation(s)
- A R Kpossou
- Clinique universitaire d'hépatogastroentérologie, Centre national hospitalier universitaire Hubert-Koutoukou-Maga (CNHU-HKM) de Cotonou, Bénin.,2 Service de chirurgie viscérale, CNHU-HKM, Cotonou, Bénin
| | - D G Gbessi
- Service de chirurgie viscérale, CNHU-HKM, Cotonou, Bénin
| | - F H R Gnangnon
- Service de chirurgie viscérale, CNHU-HKM, Cotonou, Bénin
| | - K D C E Kanhonou
- Clinique universitaire d'hépatogastroentérologie, Centre national hospitalier universitaire Hubert-Koutoukou-Maga (CNHU-HKM) de Cotonou, Bénin.,2 Service de chirurgie viscérale, CNHU-HKM, Cotonou, Bénin
| | - C N M Sokpon
- Clinique universitaire d'hépatogastroentérologie, Centre national hospitalier universitaire Hubert-Koutoukou-Maga (CNHU-HKM) de Cotonou, Bénin.,2 Service de chirurgie viscérale, CNHU-HKM, Cotonou, Bénin
| | - R K Vignon
- Clinique universitaire d'hépatogastroentérologie, Centre national hospitalier universitaire Hubert-Koutoukou-Maga (CNHU-HKM) de Cotonou, Bénin.,2 Service de chirurgie viscérale, CNHU-HKM, Cotonou, Bénin
| | - F Séidou
- Laboratoire d'anatomopathologie et de cytopathologie, faculté des sciences de la santé, Cotonou, Bénin
| | - J Séhonou
- Clinique universitaire d'hépatogastroentérologie, Centre national hospitalier universitaire Hubert-Koutoukou-Maga (CNHU-HKM) de Cotonou, Bénin.,2 Service de chirurgie viscérale, CNHU-HKM, Cotonou, Bénin
| |
Collapse
|
14
|
Maalej SM, Ben Abdallah R, Hammami A. [Antibiotic Susceptibility of Haemophilus influenzae in Sfax: Two Years after the Introduction of the Hib Vaccination in Tunisia]. Bull Soc Pathol Exot 2020; 113:12-16. [PMID: 32881444 DOI: 10.3166/bspe-2020-0114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/19/2020] [Accepted: 03/14/2020] [Indexed: 06/11/2023]
Abstract
A retrospective study was conducted at the Sfax hospitals between 2013 and 2014 to study the susceptibility to antibiotics of Haemophilus influenzae after the introduction of Hib vaccination in Tunisia. Capsular typing was done by PCR. MICs for β-lactams were determined by E-test®. The blaTEM, blaROB and ftsI genes were searched using PCR. Among the 259 strains of H. influenzae isolated, 248 (95.7%) were non-invasive. Five strains were encapsulated (3 type b and 2 type c). Resistance rates were 33.4% for ampicillin, 10.4% for amoxicillin-clavulanic acid, 2.3% for cefixime, 1.1% for cefotaxime and 1.9% for fluoroquinolones. Among the strains resistant to β-lactams, 67 produced β-lactamase type TEM and 40 had a modification of PLP3. This study shows the change in the epidemiology of H. influenzae induced by vaccination with a dramatic decrease of invasive infections. Replacement with other capsular types or with non-typable strains that may be resistant to antibiotics requires continuous surveillance for H. influenzae infections.
Collapse
Affiliation(s)
- S Mezghani Maalej
- Laboratoire de microbiologie, CHU Habib-Bourguiba, Sfax, Tunisie
- Laboratoire de microbiologie, faculté de médecine de Sfax, université de Sfax, Tunisie
| | - R Ben Abdallah
- Laboratoire de microbiologie, CHU Habib-Bourguiba, Sfax, Tunisie
- Laboratoire de microbiologie, faculté de médecine de Sfax, université de Sfax, Tunisie
| | - A Hammami
- Laboratoire de microbiologie, CHU Habib-Bourguiba, Sfax, Tunisie
- Laboratoire de microbiologie, faculté de médecine de Sfax, université de Sfax, Tunisie
| |
Collapse
|
15
|
Salissou GM, Moustapha N, Kaba C, Coumba D, Saïdou D. [Sjögren's Syndrome: Epidemiological, Diagnostic, Therapeutic and Evolutionary Aspects in the Aristide-Le-Dantec Teaching Hospital of Dakar, Senegal (2012-2016)]. Bull Soc Pathol Exot 2020; 113:136-142. [PMID: 33825393 DOI: 10.3166/bspe-2020-0124] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Sjögren's syndrome (SS) is an autoimmune epithelitis, rarely described in black Africa. We report its epidemiological, diagnostic, therapeutic and evolutionary aspects in a Senegalese hospital environment. A retrospective, crosssectional study was carried out in the rheumatology and internal medicine departments of Aristide-Le-Dantec University Hospital of Dakar, between January 2012 and September 2016, where the observations of SS whose diagnosis, in line with the American-European consensus criteria of 2002, were enrolled. We collected 370 observations of SS, 327 women and 43 men, a sex-ratio of 1:9. These were 251 primitive forms (pSS) and 119 secondary forms (sSS). The hospital prevalence of pSS was 5%. The mean age was 42 ± 15 years and the time taken for diagnosis was 7 years. The familial forms totaled 47 index cases with a relative risk of occurrence of the disease estimated at 6.3% for firstdegree relatives. The juvenile forms totaled 7 cases of pSS. Dry syndrome was constant: oral (87%) and ocular (84%). Extra glandular manifestations were present in 87%. Arthritis was erosive in 75 cases and secondary to Rheumatoid arthritis. Autoantibodies (rheumatoid factors [49/147], anti-CCP [24/79], Sjögren's syndrome autoantigen A [anti- Ro/SSA] 41/140, Sjögren's syndrome autoantigen B [anti-La/SSB] [22/140], anti-nuclear [14/55] and cryoglobulin 1) were objectified. The histology practiced in 253/370 patients was contributory in 229 of them. According to the ESSPRI score (Eular Sjögren's Syndrome Patient Reported Index), 77% of patients had unbearable symptoms. NHP (Nottingham Health Profile) and SF-36 (Short Form [36] Health Survey) confirmed this deterioration in the quality of life. The ESSDAI score (Eular Sjögren Syndrome Disease Activity Index) showed persistent activity of the disease. The evolution was overall favorable. The hospital prevalence of pSS was 5%. It is predominant in women with an average age of 42 years. Glandular and systemic manifestations are frequent. The functional repercussions and the alteration of the quality of life are notable.
Collapse
Affiliation(s)
| | - N Moustapha
- Service de rhumatologie, CHU Aristide-Le-Dantec, Dakar, Sénégal
| | - C Kaba
- Service de rhumatologie, CHU Aristide-Le-Dantec, Dakar, Sénégal
| | - D Coumba
- Service de rhumatologie, CHU Aristide-Le-Dantec, Dakar, Sénégal
| | - D Saïdou
- Service de rhumatologie, CHU Aristide-Le-Dantec, Dakar, Sénégal
| |
Collapse
|
16
|
Akakpo AS, Saka B, Téclessou JN, Mouhari-Toure A, Amegbor K, Kassang P, Kombaté K, Pitché P. [Atypical Localization of a Case of Leprosy in Lomé (Togo)]. ACTA ACUST UNITED AC 2019; 112:133-136. [PMID: 31825189 DOI: 10.3166/bspe-2019-0095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2019] [Accepted: 10/29/2019] [Indexed: 11/20/2022]
Abstract
This was a 50-year-old woman with a selling activity living in Lomé who came for a consultation in March 2016 for a facial flushing that had been going on for 2 months without pain or pruritus. On examination, there was a single, erythemato-squamous closet of the right hemiface. There was no infiltration of the right ear. There was moderate cutaneous heat compared to the left hemiface which was without any lesion. Examination of nails, hair, palms and plants was normal. There was no hypertrophy of the peripheral nerves (superficial cervical plexus, ulnar, median). The face was not fixed. Complementary examinations noted a normal blood count and negative HIV status. Histology performed on a biopsy fragment concluded tuberculoid leprosy. The patient was first put on WHO multidrug therapy during 6 months. But one month after stopping this treatment, the lesions resumed. She was referred to a multibacillary leprosy protocol during one year. She had been seen 4 months after stopping treatment, without recurrence. It is important not to ignore leprosy in case of atypical erythema of the face even in the absence of other evocative signs and to perform a biopsy to the slightest doubt.
Collapse
Affiliation(s)
- A S Akakpo
- Service de dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, Togo
| | - B Saka
- Service de dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, Togo
| | - J N Téclessou
- Service de dermatologie et IST, CHU Campus, Université de Lomé, Togo
| | - A Mouhari-Toure
- Service de dermatologie et IST, CHU Kara, Université de Kara, Togo
| | - K Amegbor
- Service d'anatomie pathologique, CHU Sylvanus Olympio, Université de Lomé, Togo
| | - P Kassang
- Service de dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, Togo
| | - K Kombaté
- Service de dermatologie et IST, CHU Campus, Université de Lomé, Togo
| | - P Pitché
- Service de dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, Togo
| |
Collapse
|
17
|
Sarr L, Diouf A, Diongue K, Dembélé B, Daffé M, Diouf BA, Gueye AB, Diao S, Coulibaly NF, Diémé C, Sy MH. [Pulmonary Metastase of a Knee Mycetoma in Senegal]. ACTA ACUST UNITED AC 2019; 112:129-132. [PMID: 31825187 DOI: 10.3166/bspe-2019-0091] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2019] [Accepted: 10/29/2019] [Indexed: 11/20/2022]
Abstract
Mycetoma is transmitted by thorns infected. The commonest site for mycetoma is the foot. The primary pulmonary are rare and usually secondary to other primary site. We report a case of pulmonary fungal mycetoma secondary to primary site in the knee. We do a review of the literature and we discuss the way of dissemination.
Collapse
Affiliation(s)
- L Sarr
- Service d'orthopédie-traumatologie, hôpital Aristide Le Dantec, Dakar, Sénégal
| | - A Diouf
- Service d'orthopédie-traumatologie, hôpital Aristide Le Dantec, Dakar, Sénégal
| | - K Diongue
- Services de parasitologie et de mycologie, hôpital Aristide Le Dantec, Dakar, Sénégal
| | - B Dembélé
- Service d'orthopédie-traumatologie, hôpital Aristide Le Dantec, Dakar, Sénégal
| | - M Daffé
- Service d'orthopédie-traumatologie, hôpital Aristide Le Dantec, Dakar, Sénégal
| | - B A Diouf
- Service d'orthopédie-traumatologie, hôpital Aristide Le Dantec, Dakar, Sénégal
| | - A B Gueye
- Centre hospitalier de l'ordre de Malte, Dakar, Sénégal
| | - S Diao
- Service d'orthopédie-traumatologie, hôpital général de Grand Yoff, Dakar, Sénégal
| | - N F Coulibaly
- Service d'orthopédie-traumatologie, hôpital Aristide Le Dantec, Dakar, Sénégal
| | - C Diémé
- Service d'orthopédie-traumatologie, hôpital Aristide Le Dantec, Dakar, Sénégal
| | - M H Sy
- Service d'orthopédie-traumatologie, hôpital général de Grand Yoff, Dakar, Sénégal
| |
Collapse
|
18
|
Pesqué R, Percheron R, Cordonnier AL, Steelandt J, Paubel P, Pineau J, Prognon P, Martelli N. [Health technology assessment of innovative medical devices: Timing and decision at national and local level]. Ann Pharm Fr 2019; 78:189-197. [PMID: 31806152 DOI: 10.1016/j.pharma.2019.10.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2019] [Revised: 10/11/2019] [Accepted: 10/23/2019] [Indexed: 10/25/2022]
Abstract
INTRODUCTION The Medical Device Committee (CODIMS) evaluates all innovative medical devices (MD) before their introduction in the hospitals of the Assistance publique-hôpitaux de Paris (AP-HP). At the national level, the Medical Device and Health Technology Evaluation Committee (CNEDiMTS) provides recommendation for MD with respects to reimbursement by the National Health Insurance Fund. The aim of this study is to compare the recommendations of both committees and to analyze their timing on a six-year period. MATERIAL AND METHOD We selected all innovative MD assessed by the CODIMS between 2013 and 2018. We retrieved all the recommendations for these MD from the CNEDiMTS. We performed quantitative and qualitative analysis of data collected. RESULTS On 30 innovative MD assessed by both the CODIMS and the CNEDiMTS, 11 (37%) evaluations were performed by the CODIMS before the CNEDiMTS evaluation. They occurred approximately a year before the CNEDiMTS recommendation (an average of 378 days). Among the 25 MD with a recommendation of both committees, the two opinions were consistent in 88 per cent of all cases. DISCUSSION/CONCLUSION This study highlights that there is a good consistency between the recommendations of both committees. This suggests that the MD evaluations conducted at the hospital level are relevant and timely. Finally, a better coordination between the national and local levels should be promoted for the MD assessment.
Collapse
Affiliation(s)
- R Pesqué
- Service pharmacie, hôpital européen Georges-Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France
| | - R Percheron
- Service pharmacie, hôpital européen Georges-Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France
| | - A-L Cordonnier
- Service évaluations pharmaceutiques et bon usage, Agence générale des équipements et des produits de santé, AP-HP, 7, rue du Fer à Moulin, 75005 Paris, France
| | - J Steelandt
- Service évaluations pharmaceutiques et bon usage, Agence générale des équipements et des produits de santé, AP-HP, 7, rue du Fer à Moulin, 75005 Paris, France
| | - P Paubel
- Service évaluations pharmaceutiques et bon usage, Agence générale des équipements et des produits de santé, AP-HP, 7, rue du Fer à Moulin, 75005 Paris, France; Inserm UMR S 1145, faculté de pharmacie de Paris, Institut droit et santé, université de Paris, 4, avenue de l'Observatoire, 75006 Paris, France
| | - J Pineau
- Service pharmacie, hôpital européen Georges-Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France
| | - P Prognon
- Service pharmacie, hôpital européen Georges-Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France
| | - N Martelli
- Service pharmacie, hôpital européen Georges-Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France; EA7358 GRADES, université Paris-Sud, université Paris-Saclay, 5, rue Jean-Baptiste Clément, 92290 Châtenay-Malabry, France.
| |
Collapse
|
19
|
Noude Teclessou J, Séfako Akakpo A, Kassang P, Saka B, Mouhari-Toure A, Kombate K, Pitche P. [Clinical Spectrum of Herpes Zoster in Lomé (Togo), and Factors Associated with HIV Infection]. ACTA ACUST UNITED AC 2019; 112:255-259. [PMID: 32880129 DOI: 10.3166/bspe-2020-0104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Accepted: 01/09/2020] [Indexed: 11/20/2022]
Abstract
We have studied the epidemiological and clinical profile of herpes zoster in patients consulting at different hospitals in Lomé (Togo). This is a retrospective study of the records of the patient consulting for herpes zoster in the dermatology departments of these hospitals from 2009 to 2018. Of the 20,548 patients seen in the different departments, 254 (1.2%) had herpes zoster. The mean age of the patients was 41.6 ± 16 years, and the sex-ratio (M/F) was 0.81. Thirty-one (12.24%) patients were known to be HIVpositive and 105 (41.33%) agreed to be tested for HIV after admission. Thirty-five (33.3%) of these 105 patients were found to be HIV positive. Factors associated with HIV infection in 136 patients with the known HIV status were as follows: history of herpes zoster (P < 0.01, compared with the seronegatives), hemorrhagic lesions (P < 0.001), multimetameric location (P < 0.0001), and involvement of the cephalic extremity (P < 0.0001). Post-herpetic pain was observed in 32 (12.6%) patients.
Collapse
Affiliation(s)
- J Noude Teclessou
- Service de dermatologie CHU de Lomé, Faculté des sciences de la santé (FSS), université de Lomé
| | - A Séfako Akakpo
- Service de dermatologie CHU de Lomé, Faculté des sciences de la santé (FSS), université de Lomé
| | - P Kassang
- Service de dermatologie, CHU de Lomé
| | - B Saka
- Service de dermatologie CHU de Lomé, Faculté des sciences de la santé (FSS), université de Lomé
| | - A Mouhari-Toure
- Service de dermatologie, CHU Kara, Faculté des sciences de santé (FSS), université de Kara
| | - K Kombate
- Service de dermatologie CHU de Lomé, Faculté des sciences de la santé (FSS), université de Lomé
| | - P Pitche
- Service de dermatologie CHU de Lomé, Faculté des sciences de la santé (FSS), université de Lomé
| |
Collapse
|
20
|
Oury Safiatou Diallo M, Diaré A, Amara Traoré F, Bangaly Sako F, Saliou Sow M, Oumou Sylla A, Bah I, Sylla K, Cisse M. [Tetanus Observation Over a 12-Month Period in Conakry, Guinea]. Bull Soc Pathol Exot 2019; 112:251-254. [PMID: 32880131 DOI: 10.3166/bspe-2020-0105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/15/2019] [Accepted: 01/10/2020] [Indexed: 06/11/2023]
Abstract
The objective of this study was to determine the factors associated with death in patients hospitalized for tetanus. This study collected prospectively over a twelve (12) month period, the epidemiological, clinical and evolutionary data, and proceeded to an analysis of the factors associated with the death of hospitalized patients. We collected 32 patients with tetanus, or 5% of the total number of hospitalized patients. The average age was 36 ± 14 years. The sex ratio was 15 (30/2). The iatrogenic entrance door was found in 5 (15%) patients. Respiratory complications were the most frequent, ie 9 cases (28%). The most commonly used treatment regimen (28 cases, 88%) was the combination of metronidazole, diazepam, and anti-tetanus serum with an average hospital stay of 23 days. A Dakar prognostic score greater than or equal to 3, the presence of complications and a hospital stay of less than or equal to 7 days were the main factors associated with the death. Tetanus remains common in Guinea with a high lethality rate. Improving immunization coverage is imperative.
Collapse
Affiliation(s)
- M Oury Safiatou Diallo
- Service des maladies infectieuses de l'hôpital national Donka, Université Gamal Abdel Nasser de Conakry, Conakry, République de Guinée
| | - A Diaré
- Service des maladies infectieuses de l'hôpital national Donka, Université Gamal Abdel Nasser de Conakry, Conakry, République de Guinée
| | - F Amara Traoré
- Service des maladies infectieuses de l'hôpital national Donka, Université Gamal Abdel Nasser de Conakry, Conakry, République de Guinée
| | - F Bangaly Sako
- Service des maladies infectieuses de l'hôpital national Donka, Université Gamal Abdel Nasser de Conakry, Conakry, République de Guinée
| | - M Saliou Sow
- Service des maladies infectieuses de l'hôpital national Donka, Université Gamal Abdel Nasser de Conakry, Conakry, République de Guinée
| | - A Oumou Sylla
- Service des maladies infectieuses de l'hôpital national Donka, Université Gamal Abdel Nasser de Conakry, Conakry, République de Guinée
| | - I Bah
- Service des maladies infectieuses de l'hôpital national Donka, Université Gamal Abdel Nasser de Conakry, Conakry, République de Guinée
| | - K Sylla
- Service des maladies infectieuses de l'hôpital national Donka, Université Gamal Abdel Nasser de Conakry, Conakry, République de Guinée
| | - M Cisse
- Service de dermatologie de l'hôpital national Donka, Université Gamal Abdel Nasser de Conakry, Conakry, République de Guinée
| |
Collapse
|
21
|
Gaye NM, Ndiaye-Diop MT, Fall M, Ka M, Fall SAA, Diop AM, Kahwaji J, Cissé-Diallo VMP, Mbaye M, Thioub M, Mbodji AB, Mbaye KA, Diagne R, Bakhoum M, Cissé O, Bâ EHM, Diagne NS, Diop-Sène MS, Basse-Faye AM, Sow AD, Sarr MM, Seck LB, Touré K, Ndiaye M, Diop AG. [Neuro-Behçet in a Sub-Saharan Africa Country: a Series of Sixteen Patients in Fann Teaching Hospital, Dakar, Senegal]. Bull Soc Pathol Exot 2019; 112:137-146. [PMID: 31825191 DOI: 10.3166/bspe-2019-0094] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/20/2019] [Accepted: 10/29/2019] [Indexed: 06/10/2023]
Abstract
Neuro-Behçet (NB) African studies are mainly North African, but Sub-Saharan Africa is not to be outdone. Our aim was to describe diagnostic and therapeutic features of NB in a Senegalese series collected in Dakar. This was a descriptive and retrospective study conducted at the Neurology department of Fann Teaching Hospital in Dakar, Senegal. All patients who met the NB's diagnostic criteria were included. Sixteen patients were collected, 14 males and 2 females with an average age of 40 years [18-71]. The main neurological signs were motor deficit (13 cases), headache (10 cases), and language disorders (4 cases). Extra-neurological signs were dermatological (14 cases), ocular (2 cases), and articular (2 cases) with aseptic unilateral gonarthritis. Fever was present in 9 patients. Neurological involvement was mostly isolated parenchymal (8 cases) or mixed (6 cases). The main clinical forms of NB were rhombencephalitis (8 cases) and retrobulbar optic neuritis (4 cases). Seven patients had a cerebral angio-Behçet with cerebral venous thrombosis (3 cases), ischemic stroke (2 cases), and intracerebral hematoma (2 cases). Under prednisone (16 cases) and azathioprine (3 cases), the short-term clinical outcome was mostly favorable (14 cases) with a modified Rankin scale at 2. NB is an under-diagnosed adult male disease in Sub-Saharan Africa and further studies are needed.
Collapse
Affiliation(s)
- N M Gaye
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - M T Ndiaye-Diop
- Service de dermatologie, hôpital Institut d'hygiène social de Dakar, Sénégal
| | - M Fall
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - M Ka
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - S A A Fall
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - A M Diop
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - J Kahwaji
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - V M P Cissé-Diallo
- Service des maladies infectieuses et tropicales, centre hospitalier national universitaire de Fann, Dakar, Sénégal
| | - M Mbaye
- Service de neurochirurgie, centre hospitalier national universitaire de Fann, Dakar, Sénégal
| | - M Thioub
- Service de neurochirurgie, centre hospitalier national universitaire de Fann, Dakar, Sénégal
| | - A B Mbodji
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - K A Mbaye
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - R Diagne
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - M Bakhoum
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - O Cissé
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - E H M Bâ
- Service de psychiatrie, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - N S Diagne
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - M S Diop-Sène
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - A M Basse-Faye
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - A D Sow
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - M M Sarr
- UFR des sciences de la santé, université de Thiès, Sénégal
| | - L B Seck
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - K Touré
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - M Ndiaye
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| | - A G Diop
- Clinique neurologique, centre hospitalier national universitaire de Fann, BP 5035, Dakar, Sénégal
| |
Collapse
|
22
|
Dégboé B, Koudoukpo C, Elégbédé N, Agbéssi N, Habib A, d'Almeïda C, Ngolo P, Akpadjan F, Adégbidi H, Atadokpèdé F. [Hookworm-related folliculitis in a woman performing skin bleaching in Benin]. Bull Soc Pathol Exot 2019; 112:190-194. [PMID: 32003196 DOI: 10.3166/bspe-2019-0099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/05/2019] [Accepted: 12/09/2019] [Indexed: 06/10/2023]
Abstract
Hookworm-related cutaneous larva migrans is caused by the subcutaneous migration of hookworm larvae. The characteristic sign is a serpiginous cutaneous track. Folliculitis is an uncommon clinical manifestation. We report a case of hookworm-related folliculitis in a woman performing skin bleaching. A 33-year-old woman presented with a widespread cutaneous eruption made of erythematous and itchy follicular papulo-nodules, with erythematous serpiginous tracks, about 5-10cm long and numerous streaks of scratching, located on the limbs, buttocks and trunk. The cutaneous lesions occurred two days after contact with the floor of a warehouse contamined by faeces of cats. The lesions have been evolving for a week and have been treated with antibiotics without success. Clinical examination found cutaneous atrophy, purple stretch marks and hyperpigmentation of dorsal parts of fingers joints. The patient reported having been using bleaching cosmetics containing topical steroids and hydroquinone for twelve years. She was cured within 4 weeks with oral albendazole 400mg per day during 7 consecutive days.
Collapse
Affiliation(s)
- B Dégboé
- Clinique universitaire de dermatologie-vénérologie du Centre national hospitalier et universitaire de Cotonou, Faculté des sciences de la santé, Université d'Abomey-Calavi, Bénin
| | - C Koudoukpo
- Service de dermatologie-vénérologie du Centre hospitalier universitaire départemental du Borgou-Alibori, Faculté de médecine, Université de Parakou, Bénin
| | - N Elégbédé
- Clinique universitaire de dermatologie-vénérologie du Centre national hospitalier et universitaire de Cotonou, Faculté des sciences de la santé, Université d'Abomey-Calavi, Bénin
| | - N Agbéssi
- Service de dermatologie-vénérologie du Centre hospitalier universitaire départemental du Borgou-Alibori, Faculté de médecine, Université de Parakou, Bénin
| | - A Habib
- Clinique universitaire de dermatologie-vénérologie du Centre national hospitalier et universitaire de Cotonou, Faculté des sciences de la santé, Université d'Abomey-Calavi, Bénin
| | - C d'Almeïda
- Clinique universitaire de dermatologie-vénérologie du Centre national hospitalier et universitaire de Cotonou, Faculté des sciences de la santé, Université d'Abomey-Calavi, Bénin
| | - P Ngolo
- Clinique universitaire de dermatologie-vénérologie du Centre national hospitalier et universitaire de Cotonou, Faculté des sciences de la santé, Université d'Abomey-Calavi, Bénin
| | - F Akpadjan
- Clinique universitaire de dermatologie-vénérologie du Centre national hospitalier et universitaire de Cotonou, Faculté des sciences de la santé, Université d'Abomey-Calavi, Bénin
| | - H Adégbidi
- Clinique universitaire de dermatologie-vénérologie du Centre national hospitalier et universitaire de Cotonou, Faculté des sciences de la santé, Université d'Abomey-Calavi, Bénin
| | - F Atadokpèdé
- Clinique universitaire de dermatologie-vénérologie du Centre national hospitalier et universitaire de Cotonou, Faculté des sciences de la santé, Université d'Abomey-Calavi, Bénin
| |
Collapse
|
23
|
Abstract
The hospital costing process implies access to various sources of data. Whether a micro-costing or a gross-costing approach is used, the choice of the methodology is based on a compromise between the cost of data collection, data accuracy, and data transferability. This work describes the data sources available in France and the access modalities that are used, as well as the main advantages and shortcomings of: (1) the local unit costs, (2) the hospital analytical accounting, (3) the Angers database, (4) the National Health Cost Studies, (5) the INTER CHR/U databases, (6) the Program for Medicalizing Information Systems, and (7) the public health insurance databases.
Collapse
Affiliation(s)
- G Mercier
- Unité de recherche médico-économique, département d'information médicale, UMR 5112 CNRS-université de Montpellier, CHU de Montpellier, 34000 Montpellier, France.
| | - N Costa
- Inserm UMR 1027, unité d'évaluation médico-économique (UEME), CHU de Toulouse, 31059 Toulouse cedex 9, France.
| | - C Dutot
- Département d'information médicale, CHU de Montpellier, 34090 Montpellier, France.
| | - V-P Riche
- Cellule innovation, direction de la recherche, CHU de Nantes, 44000 Nantes, France.
| | | |
Collapse
|
24
|
Morelle M, Plantier M, Dervaux B, Pagès A, Deniès F, Havet N, Perrier L. [Methods for the analysis and treatment of cost data by micro- and gross-costing approaches]. Rev Epidemiol Sante Publique 2018. [PMID: 29530442 DOI: 10.1016/j.respe.2018.02.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
This work addresses the analysis of individual cost data in the setting of interventional or observational studies using statistical analysis software once the costs per patient have been estimated. It is in fact necessary to be able to present and describe data in an appropriate manner in each of the studied health strategies and to test whether the difference in costs observed between treatment groups is due to chance or not. Furthermore, cost analysis differs from conventional statistical analysis in that cost data have a certain number of specific properties, including their use by health decision-makers. This work also addresses the difficulties that generally arise in regard to the distribution of cost; it explains why the mathematical average constitutes the only relevant measure for economists; and it outlines which analyses are required for inter-strategy cost comparisons. It also covers the issue of missing or censored data, features that are inherent to information collected regarding costs and to sensitivity analyses.
Collapse
Affiliation(s)
- M Morelle
- GATE L-SE UMR 5824, centre Léon-Bérard, université de Lyon, université Claude-Bernard Lyon 1, 28, rue Laennec, 69008 Lyon, France.
| | - M Plantier
- ISFA, laboratoire SAF, université Lyon 1, 50, avenue Tony-Garnier, 69100 Lyon, France
| | - B Dervaux
- Cellule innovation, DRCI, CHRU de Lille, 2, avenue Oscar-Lambret, 59000 Lille, France
| | - A Pagès
- Inserm UMR 1027, CHU de Toulouse, 37, allées Jules-Guesde, 31059 Toulouse, France
| | - F Deniès
- Cellule innovation, DRCI, CHRU de Lille, 2, avenue Oscar-Lambret, 59000 Lille, France
| | - N Havet
- ISFA, laboratoire SAF, université Lyon 1, 50, avenue Tony-Garnier, 69100 Lyon, France
| | - L Perrier
- GATE L-SE UMR 5824, centre Léon-Bérard, université de Lyon, université Claude-Bernard Lyon 1, 28, rue Laennec, 69008 Lyon, France
| |
Collapse
|
25
|
Margier J, Baffert S, Le Corroller-Soriano AG; French Costing Group. [Standard or specific unit costs: Which criteria for choosing an economic evaluation of health strategies in multicentric studies?]. Rev Epidemiol Sante Publique 2018; 66 Suppl 2:S93-9. [PMID: 29526356 DOI: 10.1016/j.respe.2018.02.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The question of what monetary value should be assigned to consumed resources, that is to say the choice of the unit cost, is a major consideration in terms of impact on the cost analysis results. To date, no agreement has been reached regarding this methodological question. The choices made by methodologists and the subsequent impact on the results of the analysis are only rarely put forward. This work addresses the theoretical framework of health strategy evaluations that can be carried out either in the normative framework of the conventional economic approach of well-being, referred to as welfarist, or in that of an approach referred to as extra-welfarist. It also provides elements that help clarify the choice of the hospital unit costs used to calculate the cost of health strategies, so as to reconcile the use of such studies and improve their comparability. What is preferable, opting for specific per hospital unit costs or applying a standard unit cost to all facilities? How should a standard cost be calculated? Is it appropriate to calculate an average of the unit costs, as recommended by certain guidelines? The advantages and the limitations of the various modes of assessing hospital resources in the setting of multicentric trials are discussed.
Collapse
|
26
|
Abstract
Cost analysis has become increasingly commonplace in healthcare facilities in recent years. Regardless of the aim, the first consideration for a hospital costing process is to determine the point of view, or perspective, to adopt. Should the cost figures reflect the healthcare facility's point of view or enlighten perspectives for the public health insurance system? Another consideration is in regard to the method to adopt, as there are several. The two most widely used methods to determine the costs of hospital treatments in France are the micro-costing method and the gross-costing method. The aims of this work are: (1) to describe each of these methods (e.g. data collection, assignment of monetary value to resource consumption) with their advantages and shortcomings as they relate to the difficulties encountered with their implementation in hospitals; (2) to present a review of the literature comparing the two methods and their possible combination; and (3) to propose ways to address the questions that need to be asked before compiling resource consumption data and assigning monetary value to hospital costs. A final diagram summarizes methodologies to be preferred according to the evaluation strategy and the impact on patient care.
Collapse
Affiliation(s)
- P Guerre
- Service d'évaluation économique en santé, Direction de la recherche clinique et de l'innovation (DRCI), Service d'évaluation économique en santé, hospices civils de Lyon, 3, quai des Célestins, 69002 Lyon, France.
| | - N Hayes
- Direction de la recherche clinique et de l'innovation (DRCI), CHU de Bordeaux, 12, rue Dubernat, 33404 Talence cedex 1, France
| | - A-C Bertaux
- Délégation à la recherche clinique et à l'innovation (DRCI), CHU Dijon-Bourgogne, 14, rue Gaffarel, 21079 Dijon cedex, France
| | | |
Collapse
|
27
|
Khefacha Aissa S, Ghali H, Ben Rejeb M, Ben Fredj S, Ben Ouanes R, Dhidah L, Said Latiri H. [Smoking attitudes and behavior of the hospital staff Sahloul (Sousse, Tunisia)]. Rev Mal Respir 2018; 35:256-263. [PMID: 29397302 DOI: 10.1016/j.rmr.2017.12.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2016] [Accepted: 01/30/2017] [Indexed: 11/17/2022]
Abstract
BACKGROUND Smoking is a major public health problem. Legislation banning smoking in public institutions exists but is not strictly enforced, particularly in health facilities. Therefore health workers have a crucial role to play in the control of smoking on account of their contact with patients and their credibility and moral authority in health matters. They can help patients by their advice and by abstaining from smoking in the hospital themselves. The aim of our study was to determine the prevalence of smoking among medical staff at the University Hospital of Sahloul in Sousse and their attitudes and behaviour with regard to smoking. METHODS The data came from a descriptive cross-sectional study conducted during the year 2013-2014 using a self-administered questionnaire and included the health personnel of all services and laboratories of the University Hospital of Sahloul in Sousse. RESULTS The participation rate was 71% (768/1081). Our study population was predominantly female (51%) with a mean age of 37.8 (±11.3) years. The overall prevalence of smoking was 21%. It was significantly higher among men (38.8%) than women (4.6%). This prevalence was higher among physicians/pharmacists (29.5%). More than half the smokers (58%) started smoking between the age of 19 and 25 years. Nicotine dependence was moderate among 27.4% and strong among 18.3% of smokers. The average dependence score was 4.1±2.4 [0-9] with a median of 4.0. Two-thirds of smokers (66.5%) reported smoking in the workplace. CONCLUSION Confronted with the problem of tobacco, health institutions should find solutions for the prevention of smoking in hospitals. It seems necessary to train and involve hospital staff in anti-tobacco measures and to help smokers to quit in order to make our hospital a tobacco smoke free space.
Collapse
Affiliation(s)
- S Khefacha Aissa
- Service de prévention et de sécurité des soins, CHU Sahloul, Hammam, 4054 Sousse, Tunisie; Consultation d'aide au sevrage tabagique, CHU Sahloul, Sousse, Tunisie.
| | - H Ghali
- Service de prévention et de sécurité des soins, CHU Sahloul, Hammam, 4054 Sousse, Tunisie
| | - M Ben Rejeb
- Service de prévention et de sécurité des soins, CHU Sahloul, Hammam, 4054 Sousse, Tunisie; Département de médecine préventive et communautaire, faculté de médecine, Sousse, Tunisie
| | - S Ben Fredj
- Service de prévention et de sécurité des soins, CHU Sahloul, Hammam, 4054 Sousse, Tunisie
| | - R Ben Ouanes
- Service de prévention et de sécurité des soins, CHU Sahloul, Hammam, 4054 Sousse, Tunisie
| | - L Dhidah
- Service de prévention et de sécurité des soins, CHU Sahloul, Hammam, 4054 Sousse, Tunisie
| | - H Said Latiri
- Service de prévention et de sécurité des soins, CHU Sahloul, Hammam, 4054 Sousse, Tunisie; Département de médecine préventive et communautaire, faculté de médecine, Sousse, Tunisie
| |
Collapse
|
28
|
Jamet N, Thivilliers AP, Paubel P, Chevalier D, Bourguignon S, Bézie Y. [Use of a Delphi survey to assess the hospital economic impact of innovative products: The example of idarucizumab a dabigatran-specific reversal agent]. Ann Pharm Fr 2017; 75:480-488. [PMID: 28818320 DOI: 10.1016/j.pharma.2017.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2017] [Revised: 06/20/2017] [Accepted: 06/29/2017] [Indexed: 11/30/2022]
Abstract
OBJECTIVES The economic impact of therapeutic innovations on the hospital patient management cannot be easily estimated. The objective of this study is to illustrate the use of a Delphi survey as a support tool to identify the changes following the use of idarucizumab in dabigatran-treated patients with uncontrolled/life-threatening bleeding or who required emergency surgery/urgent procedures. METHODS The Delphi questionnaires have been administrated to 8 emergency physicians or anesthetists from 6 different hospital centers. Following the answers, an economic valorization has been carried out on every parameter on which a consensus was reached (at least 4 answers showing an identical trend). A mean management cost for each etiology with and without the use of idarucizumab has thus been identified. RESULTS For gastro-intestinal and other life-threatening bleedings (excepted intracranial bleedings), the total management cost of the hospital stay was respectively 6058 € (-35%) and 6219 € (-34%) following the use of the reversal agent. The hospital management cost for intracranial bleeding is slightly increasing to 9790 € (+3%). The cost of a stay for emergency surgery decreases to 6962€ (-2%). CONCLUSIONS This study shows a positive economic impact following the use of the dabigatran-specific reversal agent for patients with uncontrolled/life-threatening bleeding excepted in the case of intracranial bleeding. Moreover, it points out that a Delphi survey is an easy way to predict the hospital economic impact of a therapeutic innovation when no other evaluation is possible.
Collapse
Affiliation(s)
- N Jamet
- Stratégique santé, 52, boulevard de l'Yerres, 91000 Evry, France
| | - A P Thivilliers
- Service pharmacie, groupe hospitalier Paris-Saint-Joseph, 185, rue Raymond-Losserand, 75014 Paris, France
| | - P Paubel
- Assistance publique-Hôpitaux de Paris, agence générale des équipements et des produits de santé, 75005 Paris, France; Faculté de pharmacie de Paris, institut Droit-et-Santé, Inserm UMR S 1145, université Paris-Descartes, Sorbonne Paris Cité, 75006 Paris, France
| | - D Chevalier
- Service pharmacie, groupe hospitalier Paris-Saint-Joseph, 185, rue Raymond-Losserand, 75014 Paris, France
| | - S Bourguignon
- Stratégique santé, 52, boulevard de l'Yerres, 91000 Evry, France
| | - Y Bézie
- Service pharmacie, groupe hospitalier Paris-Saint-Joseph, 185, rue Raymond-Losserand, 75014 Paris, France.
| |
Collapse
|
29
|
Ferrand É, Painchart L, Grimandi G, Décaudin B, Bussières JF. [The roles and the impacts of pharmacists in the management of medical devices at the hospital: A literature review]. Ann Pharm Fr 2017; 75:409-419. [PMID: 28666516 DOI: 10.1016/j.pharma.2017.05.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2017] [Revised: 05/09/2017] [Accepted: 05/22/2017] [Indexed: 11/29/2022]
Abstract
OBJECTIVES Identify the training profile and the published evidences about the roles and the impacts of hospital pharmacists in medical devices. METHODS A literature review was conducted using Google, Google Scholar and Pubmed for 1990-2016 associated with a manual search conducted in three non-indexed pharmaceutical journals for 2000-2016. RESULTS The analysis of training programs available did not allow us to identify a specific training profile. A total of 72 articles related to the roles and the impacts of the pharmacist were identified, 52 of which came from non-indexed journals. Those articles did not deal specifically about the roles and the impacts of pharmacist; however, articles were analyses for three spheres including the referencing of medical devices (n=36), the evaluation (n=19) and the distribution system (n=13). CONCLUSIONS French pharmacists have many theoretical and practical training opportunities. There are a few articles describing precisely the roles and the impacts of hospital pharmacists in medical device. It appears urgent to better document this activity in professional and indexed literature.
Collapse
Affiliation(s)
- É Ferrand
- Unité de recherche en pratique pharmaceutique, département de pharmacie, CHU Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, Montréal, QC, Canada, H3T 1C5
| | - L Painchart
- Unité de recherche en pratique pharmaceutique, département de pharmacie, CHU Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, Montréal, QC, Canada, H3T 1C5
| | - G Grimandi
- Pharmacie centrale, hôpital St-Jacques, CHU de Nantes, 85, rue St-Jacques, 44093 Nantes, France
| | - B Décaudin
- EA 7365, groupe de recherche sur les formes injectables et les technologies associées [GRITA], université de Lille, CHU de Lille, 59000 Lille, France
| | - J-F Bussières
- Unité de recherche en pratique pharmaceutique, département de pharmacie, CHU Sainte-Justine, 3175, chemin de la Côte-Sainte-Catherine, Montréal, QC, Canada, H3T 1C5; Faculté de pharmacie, université de Montréal, Montréal, QC, Canada.
| |
Collapse
|
30
|
Boudard A, Cordonnier AL, Martelli N, Lechat P, Sinègre M, Pineau J. [Introduction of Health technology assessment at hospital]. Ann Pharm Fr 2016; 74:473-81. [PMID: 27139164 DOI: 10.1016/j.pharma.2016.03.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2015] [Revised: 02/26/2016] [Accepted: 03/10/2016] [Indexed: 11/24/2022]
Abstract
INTRODUCTION The Medical Devices Committee (CODIMS) of the Assistance publique-Hôpitaux de Paris (AP-HP) is responsible for deciding whether innovative and costly sterile medical devices (SMD) should be adopted for the AP-HP network and for issuing recommendations on their proper use. The aim of this study was to qualify retrospectively the level of evidence of clinical studies used for the device evaluations by the CODIMS in 2012 and 2013 and to analyze the relationship between levels of evidence and decisions. MATERIAL AND METHOD Executive summaries written in 2012 and 2013 about studied SMD was analyzed and the level of evidence of clinical studies used was qualified in high/low levels of evidence according to the scale of Sackett et al. Then, levels of evidence were correlated to decisions published by the CODIMS. RESULTS Sixty-one files of SMD (72.1% of implantable MD) have been evaluated (225 clinical studies). Among them, only 28% of clinical studies had a high level of evidence (and 28.6% of MD at-risk) and 18% did not have any clinical studies. The CODIMS delivered an unfavourable opinion for 16 SMD: only 28 clinicals studies were available for evaluation. Among these, only 6 studies had a high level of evidence. DISCUSSION ET CONCLUSION The amount and level of evidence of clinical studies is naturally correlated to admittance of SMD. These findings suggest that the clinical evidence used to demonstrate safety and efficacy for high-risk medical devices is based on clinical studies with poor quality data, making more difficult the evaluation of SMD in hospital. The development of a multi-criteria tool to help decision-making would improve the process of SMD evaluation by the CODIMS.
Collapse
|
31
|
Filipovic-Pierucci A, Rigault A, Fagot-Campagna A, Tuppin P. [Health status of populations living in French overseas territories in 2012, compared with metropolitan France: An analysis of the national health insurance database]. Rev Epidemiol Sante Publique 2016; 64:175-83. [PMID: 27238162 DOI: 10.1016/j.respe.2016.01.099] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2015] [Revised: 10/05/2015] [Accepted: 01/20/2016] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND This study uses healthcare consumption to compare the health status of beneficiaries of the French national health insurance general scheme between individuals living in French overseas territories (FOT) and those living in metropolitan France. METHODS Data were extracted from the French national health insurance database (Sniiram) for 2012, using algorithms, 56 groups of diseases and 27 groups of hospital activity were isolated. Standardized morbidity ratio for age and sex (SMR) were used to compare FOT to mainland France. RESULTS Compared with mainland France, people living in the four FOT had high SMR for diabetes care (Guadeloupe 1.9; Martinique 1.7; Guyane 1.9; La Réunion 2.3), dialysis (2.7; 2.4; 3.8; 4.4), stroke (1.2; 1.1; 2.0; 1.5), and hospitalization for infectious diseases (1.9; 2.5; 2.4; 1.4) and obstetrics (1.4; 1.2; 1.9; 1.2). Care for inflammatory bowel disease or cancer were less frequent except for prostate in Martinique and Guadeloupe (2.3). People living in Martinique, Guadeloupe and la Reunion had more frequently care for psychotic disorders (2.0; 1.7; 1.2), dementia (1.1; 1.3; 11), epileptic seizures (1.4; 1.4; 16) and hospitalizations for burns (2.6; 1.7; 2.9). In la Reunion, people had more frequently coronary syndrome (1.3), cardiac heart failure (1.6), chronic respiratory diseases except cystic fibrosis (1.5), drug addiction (1.4) and hospitalizations for cardiovascular catheterization (1.4) and toxicology, poisoning, alcohol (1.7). Other differences were observed by gender: HIV infection, peripheral arterial disease, some chronic inflammatory disease (lupus) were more frequent in women living in Martinique or Guadeloupe, compared to women from mainland France and psychotic disorders for men. From la Reunion, men had more frequently liver and pancreatic diseases and hospitalisation for toxicology, poisoning, alcohol than men from mainland France. CONCLUSION This study highlights the utility of administrative database to compare and follow population health status considering healthcare use. Specific Public Health policies are justified for FOT, taking into account the specific context of each FOT, the necessity of prevention initiatives and screening to reduce the frequency of the chronic diseases.
Collapse
Affiliation(s)
- A Filipovic-Pierucci
- Département des études sur les pathologies et les patients (DEPP), caisse nationale d'Assurance maladie des travailleurs salariés, 26-50, avenue du Professeur-André-Lemierre, 75986 Paris cedex 20, France
| | - A Rigault
- Département des études sur les pathologies et les patients (DEPP), caisse nationale d'Assurance maladie des travailleurs salariés, 26-50, avenue du Professeur-André-Lemierre, 75986 Paris cedex 20, France
| | - A Fagot-Campagna
- Département des études sur les pathologies et les patients (DEPP), caisse nationale d'Assurance maladie des travailleurs salariés, 26-50, avenue du Professeur-André-Lemierre, 75986 Paris cedex 20, France
| | - P Tuppin
- Département des études sur les pathologies et les patients (DEPP), caisse nationale d'Assurance maladie des travailleurs salariés, 26-50, avenue du Professeur-André-Lemierre, 75986 Paris cedex 20, France.
| |
Collapse
|
32
|
Stordeur S, Vrijens F, Leroy R. Reference centres for adults with rare and complex cancers - Policy recommendations to improve the organisation of care in Belgium. Rev Epidemiol Sante Publique 2015; 64:1-6. [PMID: 26745998 DOI: 10.1016/j.respe.2015.11.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2014] [Revised: 08/24/2015] [Accepted: 11/09/2015] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND Rare and/or complex cancers call for a very specific expertise and adequate infrastructure. In Belgium, every hospital with a programme in oncology can deliver care for adults with rare and/or complex cancer types, without having demonstrated a specific know-how to adequately manage these patients. Therefore, the Minister of Health ordered a scenario for the organisation of care for adults with rare and/or complex cancers, taking into account the current Belgian situation and relevant foreign experience. METHODS Combined methods were used in this study: a literature review, the consultation of stakeholders, in depth discussions in 14 multidisciplinary groups leading to concrete proposals for several rare/complex cancers and the consultation of a panel of expert pathologists. RESULTS The core recommendation is the set-up of shared care networks around reference centres, with multidisciplinary teams of recognised expertise in specific rare/complex cancers. The definition of minimum caseloads for hospitals and medical specialists, the evaluation of the quality of care, a model of diagnostic confirmation and the set-up of a national portal website which provides information on rare and/or complex cancers and reference centres are highly recommended. CONCLUSION It is no longer practicable, efficient or ethical that every hospital or every practitioner continues to offer care for every rare/complex cancer. Improving the quality of rare/complex cancer care requires to concentrate expertise and sophisticated infrastructure in reference centres. Furthermore, the formation of networks between reference centres and peripheral centres will allow a delivery of care combining expertise and proximity. The next step is the translation of the recommendations into policy decisions. It is very well realised that this will take some courage and that a certain degree of resistance will have to be surmounted, but eventually, the best interest of the patient should prevail.
Collapse
Affiliation(s)
- S Stordeur
- Belgian Health care Knowledge Centre, 55, boulevard du Jardin-Botanique, 1000 Brussels, Belgium.
| | - F Vrijens
- Belgian Health care Knowledge Centre, 55, boulevard du Jardin-Botanique, 1000 Brussels, Belgium.
| | - R Leroy
- Belgian Health care Knowledge Centre, 55, boulevard du Jardin-Botanique, 1000 Brussels, Belgium.
| |
Collapse
|
33
|
Vonesch MA, Grangier G, Girard P, Dussart C. [Study of parenteral iron use in a health facility and its impact in terms of hospital economics]. Ann Pharm Fr 2015; 74:296-303. [PMID: 26651954 DOI: 10.1016/j.pharma.2015.11.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2015] [Revised: 11/03/2015] [Accepted: 11/04/2015] [Indexed: 10/22/2022]
Abstract
INTRODUCTION Administration of parenteral iron is a mainstay of iron deficiency treatment. Evaluation and control of this element is an issue for healthcare facilities. Study of parenteral iron use is thus to be evaluated in its impact in terms of hospital economics. MATERIALS AND METHODS Parenteral iron administrations that took place on 2014 in our healthcare facility were retrospectively identified by pharmacists. Following data were extracted from Pharma™ and Crossway™ softwares: indication, diagnostic coding and total dose of iron received. They were then compared to the summary of product characteristics. RESULTS Of 198 analyzed prescriptions, iron deficiency was known or suspected for 97% of patients. However, the total dose of iron administered was not in compliance for three quarters of prescriptions. Sixty-eight percent of patients appear under-dosed. Administration's traceability was found for two-thirds. Eighty-five hospital discharges did not have the right coding and 34 stays were charged like an external act instead sessions. Financial loss for the hospital is estimated at 49,300 euros. DISCUSSION AND CONCLUSION As part of improving practice, close pharmaceutical monitoring of parenteral iron prescribed dosing regimen is essential. Effective communication with the medical information department and regular awareness raising of prescribers should also allow to give more value to this act. Hospital economics is a real tool to aid decision-making.
Collapse
Affiliation(s)
- M-A Vonesch
- Service de pharmacie hospitalière, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France.
| | - G Grangier
- Service de pharmacie hospitalière, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France
| | - P Girard
- Département d'information médicale, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France
| | - C Dussart
- Service de pharmacie hospitalière, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France
| |
Collapse
|
34
|
Natali JP, Schwald N, Bach F, Bourgouin G, Chiffray D, Bloch F. [Benefit of a geriatric mobile team in the emergency departments: a ten-year review]. Soins Gerontol 2015; 20:22-24. [PMID: 26574128 DOI: 10.1016/j.sger.2015.09.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
A geriatric mobile team was created in the emergency department of Cochin Hospital in Paris, in 2005. This key player in the multi-disciplinary management of elderly patients in the emergency department and in the geriatric care pathway, showed, during its 10-year of existence, its utility.
Collapse
Affiliation(s)
- Jean-Philippe Natali
- Équipe d'intervention gériatrique, groupe hospitalier Cochin-Broca-Hôtel-Dieu, AP-HP, 54/56 rue Pascal, 75013 Paris, France
| | - Nathalie Schwald
- Équipe d'intervention gériatrique, groupe hospitalier Cochin-Broca-Hôtel-Dieu, AP-HP, 54/56 rue Pascal, 75013 Paris, France
| | - Frédérique Bach
- Équipe d'intervention gériatrique, groupe hospitalier Cochin-Broca-Hôtel-Dieu, AP-HP, 54/56 rue Pascal, 75013 Paris, France
| | - Gaëlle Bourgouin
- Équipe d'intervention gériatrique, groupe hospitalier Cochin-Broca-Hôtel-Dieu, AP-HP, 54/56 rue Pascal, 75013 Paris, France
| | - Dominique Chiffray
- Équipe d'intervention gériatrique, groupe hospitalier Cochin-Broca-Hôtel-Dieu, AP-HP, 54/56 rue Pascal, 75013 Paris, France
| | - Frédéric Bloch
- Équipe d'intervention gériatrique, groupe hospitalier Cochin-Broca-Hôtel-Dieu, AP-HP, 54/56 rue Pascal, 75013 Paris, France.
| |
Collapse
|
35
|
Abstract
Since 2000, the mobile team of Bretonneau Hospital in Paris has helped to improve the assessment and care management of the elderly at home by strengthening the link between community health professionals and hospital geriatric services. In January 2008, an external mobile geriatric team working with nursing homes was created for the whole of the Paris area in order to strengthen the link between care homes accommodating often highly dependent elderly people and the hospital.
Collapse
Affiliation(s)
- Christine Chansiaux-Bucalo
- Équipe mobile gériatrique externe, hôpital Beaujon, unité gériatrie aiguë, 100 boulevard du Général-Leclerc, 92118 Clichy cedex, France.
| | - Sophie Lacaille
- Équipe mobile gériatrique externe, hôpital Bretonneau, 23 rue Joseph-de-Maistre, 75018 Paris, France
| | - Claire Roy
- Équipe mobile gériatrique externe, hôpital Rothschild, 5 rue Santerre, 75012 Paris, France
| | - Catherine Bayle
- Équipe mobile gériatrique externe, hôpital Broca, 54-56 rue Pascal, 75013 Paris, France
| | | |
Collapse
|
36
|
Hem S, Tarantola A, Chheang R, Nop P, Kerléguer A. First reported case of intraocular Gnathostoma spinigerum in Cambodia. ACTA ACUST UNITED AC 2015; 108:312-5. [PMID: 26419485 DOI: 10.1007/s13149-015-0453-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2014] [Accepted: 08/11/2015] [Indexed: 10/23/2022]
Abstract
A live intraocular nematode was identified from a 37 year-old man presented with iritis, pain, redness, lacrimation, swelling, vision loss and intermittent blindness during many hours per day of the left eye. By using slit lamp examination, a worm was removed from iris in an ophthalmology outpatient department setting and sent to the Medical Microbiology Laboratory, Institut Pasteur du Cambodge. Gnathostoma spinigerum was identified, based on its typical morphology via microscopic examination. Based on our diagnosis, the patient was treated by oral albendazole and responded well to this therapy.
Collapse
Affiliation(s)
- S Hem
- Medical Biology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodge
| | - A Tarantola
- Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodge
| | - R Chheang
- Medical Biology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodge
| | - P Nop
- Medical Biology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodge
| | - A Kerléguer
- Medical Biology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodge.
| |
Collapse
|
37
|
Montmartin M, Meyer C, Euvrard E, Pazart L, Weber E, Benassarou M. [3D printing in health care facilities: What legislation in France?]. ACTA ACUST UNITED AC 2015; 116:302-7. [PMID: 26071022 DOI: 10.1016/j.revsto.2015.04.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2015] [Accepted: 04/30/2015] [Indexed: 11/16/2022]
Abstract
Health care facilities more and more use 3D printing, including making their own medical devices (MDs). However, production and marketing of MDs are regulated. The goal of our work was to clarify what is the current French regulation that should be applied concerning the production of custom-made MDs produced by 3D printing in a health care facility. MDs consist of all devices used for diagnosis, prevention, or treatment of diseases in patients. Prototypes and anatomic models are not considered as MDs and no specific laws apply to them. Cutting guides, splints, osteosynthesis plates or prosthesis are MDs. In order to become a MD manufacturer in France, a health care facility has to follow the requirements of the 93/42/CEE directive. In addition, custom-made 3D-printed MDs must follow the annex VIII of the directive. This needs the writing of a declaration of conformity and the respect of the essential requirements (proving that a MD is secure and conform to what is expected), the procedure has to be qualified, a risk analysis and a control of the biocompatibility of the material have to be fulfilled. The documents proving that these rules have been respected have to be available. Becoming a regulatory manufacturer of MD in France is possible for a health care facility but the specifications have to be respected.
Collapse
Affiliation(s)
- M Montmartin
- Génie biomédical, institut supérieur d'ingénieurs de Franche-Comté (ISIFC), université de Franche-Comté, 25030 Besançon cedex, France
| | - C Meyer
- Service de chirurgie maxillo-faciale, de stomatologie et d'odontologie hospitalière, CHU de Besançon, 3, boulevard Fleming, 25030 Besançon cedex, France; EA 4268, laboratoire intervention, innovation, ingénierie en santé (Li4S), université de Franche-Comté, 25030 Besançon cedex, France.
| | - E Euvrard
- Service de chirurgie maxillo-faciale, de stomatologie et d'odontologie hospitalière, CHU de Besançon, 3, boulevard Fleming, 25030 Besançon cedex, France; EA 4268, laboratoire intervention, innovation, ingénierie en santé (Li4S), université de Franche-Comté, 25030 Besançon cedex, France; Centre d'investigation clinique en innovation technologique (CIC-IT - Inserm CIT808), CHU de Besançon, 25030 Besançon cedex, France
| | - L Pazart
- Centre d'investigation clinique en innovation technologique (CIC-IT - Inserm CIT808), CHU de Besançon, 25030 Besançon cedex, France
| | - E Weber
- Service de chirurgie maxillo-faciale, de stomatologie et d'odontologie hospitalière, CHU de Besançon, 3, boulevard Fleming, 25030 Besançon cedex, France
| | - M Benassarou
- Service de chirurgie maxillo-faciale, de stomatologie et d'odontologie hospitalière, CHU de Besançon, 3, boulevard Fleming, 25030 Besançon cedex, France; EA 4268, laboratoire intervention, innovation, ingénierie en santé (Li4S), université de Franche-Comté, 25030 Besançon cedex, France
| |
Collapse
|
38
|
Leroyer C, Mahé I, Daurès JP, Quéré I, Aubin C, Compagnon A, Doussaint J, Schück S, Pouchain D. [Prevention of venous thromboembolic events by fondaparinux 2.5mg in patients hospitalized for an acute medical illness. ArchiMed Study]. ACTA ACUST UNITED AC 2015; 40:248-58. [PMID: 26051860 DOI: 10.1016/j.jmv.2015.05.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2014] [Accepted: 04/24/2015] [Indexed: 11/21/2022]
Abstract
OBJECTIVE To evaluate the average duration of in-hospital treatment with fondaparinux 2.5mg prescribed for venous thromboprophylaxis in acutely ill medical patients and to describe the treatment population. METHODS Prospective, observational, national, multicentre, epidemiological study, performed in France at the request of the Transparency Commission of the French National Health Authority (Haute Autorité de Santé). This is part of a larger study program that also included a study with similar design in the general practice setting. The hospital practice part of the study was conducted by hospital pharmacists who were asked to include the first 15 adult subjects hospitalized in a non-surgical ward for whom fondaparinux 2.5mg was initiated for prophylaxis. RESULTS Fifty-three pharmacists (49.5%) included a total of 718 patients. The average age was 71 ± 16 years (47%<75 years old); 54% were women. For 41% of patients, duration of fondaparinux 2.5mg administration ranged from 6 to 14 days. Eighty-five percent of patients had at least one acute illness related to the prescription of fondaparinux 2.5mg for thromboprophylaxis. Ten percent of the population had at least one risk factor listed on the Case Report Form. Characteristics of patients from the hospital practice study differ from those included in the general practice part of the ArchiMed Study program. CONCLUSION The hospital practice part of the ArchiMed Study, which is similar to "audits of practices", shows that the real-life conditions of prescription of fondaparinux 2.5mg in patients hospitalized are generally in line with guidelines with respect to indication for thromboprophylaxis in acute medical illness.
Collapse
|
39
|
Jacqueroux E, Lalande L, Meddour N, Papailhau C, Bernard E, Charroin C, Perichou J, Charpiat B, Locher F, Garcia S. [Analysis of the question-answer activity of a hospital pharmacy. Example of the handling of drug interactions]. Ann Pharm Fr 2014; 73:215-22. [PMID: 25499204 DOI: 10.1016/j.pharma.2014.10.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2014] [Revised: 10/23/2014] [Accepted: 10/30/2014] [Indexed: 11/15/2022]
Abstract
INTRODUCTION The medical care of patients generates questions among healthcare professionals. Some will necessitate an advanced research. The hospital pharmacist is at the interface between prescribers, caregivers and the medicines and is requested to answer these requests. Studies conducted in other countries showed that this question-answer activity represents a significant amount of time in daily work. In France, this topic was poorly explored. The objective of our work was to study the volume and the type of questions, the clinical situations, the time required, the medicines implicated and the sources of information used. MATERIALS AND METHODS A prospective study was conducted in the pharmacy of a university hospital. All the requests answered by the pharmaceutical team, which needed a specific research, analysis and writing of an answer were collected. RESULTS A hundred and one questions were analyzed, originating from doctors or medicals interns. Almost half concerned drug interactions, and among them, almost a fourth were not mentioned in the Summary of Product Characteristics of the medicines involved. A pharmaceutical advice was provided in 91.5% of the cases. Time dedicated to the research varied between less than 30 minutes and more than 8 hours. DISCUSSION AND CONCLUSION This study illustrates the question-answer activity of a hospital pharmacy, which is currently not taken into account as an indicator of pharmaceutical activity. A large part concerns analysis and management of drug interactions and requires a significant amount of pharmaceutical time.
Collapse
Affiliation(s)
- E Jacqueroux
- Centre de documentation et d'information pharmaceutiques, pharmacie centrale, hospices civils de Lyon, 69561 Saint-Genis Laval cedex, France
| | - L Lalande
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - N Meddour
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - C Papailhau
- Centre de documentation et d'information pharmaceutiques, pharmacie centrale, hospices civils de Lyon, 69561 Saint-Genis Laval cedex, France
| | - E Bernard
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - C Charroin
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - J Perichou
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - B Charpiat
- Service pharmacie, hôpital de la Croix-Rousse, hospices civils de Lyon, 69317 Lyon cedex 04, France
| | - F Locher
- Centre de documentation et d'information pharmaceutiques, pharmacie centrale, hospices civils de Lyon, 69561 Saint-Genis Laval cedex, France
| | - S Garcia
- Centre de documentation et d'information pharmaceutiques, pharmacie centrale, hospices civils de Lyon, 69561 Saint-Genis Laval cedex, France.
| |
Collapse
|
40
|
Guérin A, Lebel D, Marando N, Prot-Labarthe S, Bourdon O, Bussières JF. [Determinants of the evolution of hospital pharmacy in France and Quebec: Perception of hospital pharmacists]. Ann Pharm Fr 2014; 72:202-15. [PMID: 24780836 DOI: 10.1016/j.pharma.2014.01.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2013] [Revised: 01/02/2014] [Accepted: 01/07/2014] [Indexed: 10/25/2022]
Abstract
BACKGROUND Hospital pharmacy practice has evolved differently between France and Quebec. While this development is part of broader systems, French and Quebec hospitals have undergone significant changes over the years to cope with challenges, among others, the economic and demographic realities. PURPOSE The main objective is to evaluate and compare the perception of French and Quebec hospital pharmacists about the factors that have contributed to the evolution of pharmacy practice in their respective context. METHODS This is a descriptive cross-sectional study. The study focuses on a sample of experienced hospital pharmacists in France and Quebec. We targeted a convenience sample of 50 respondents per country. An online questionnaire with 15 pharmaceutical activities to which are connected nine factors that may have influenced the implementation of each of these activities in each country was used. The mean score was calculated for each of the nine factors for each activity. The perception of French and Quebec hospital pharmacists was then compared. A P value less than 0.05 was considered statistically significant. RESULTS Two hundred and sixty hospital pharmacists were directly contacted in France and 79 in Quebec. Seventy-eight French pharmacists and 77 Quebec pharmacists responded to the survey, that is a respective response rate of 30% and 97%, respectively. The hierarchy of factors that contributed to the evolution of pharmacy practice was similar between the two countries, legislative and regulatory factors as well as the concern for risk management and quality dominate; scientific human, economic factors and training have a relatively similar position. For cons, the news factor (6th in France against the 10th position in Quebec) and the academic factor (10th position in France against the 6th position in Quebec) obtained inverse scores between France and Quebec. CONCLUSION There are few data on the determinants of the evolution of hospital pharmacy in France and Quebec. The hierarchy of factors that contributed to the evolution of pharmacy practice is similar between the two countries, although differences of rank were found for the news and academic factors. Further studies are needed to better understand the factors that influence the evolution of pharmacy practice in health care institutions.
Collapse
Affiliation(s)
- A Guérin
- Unité de recherche en pratique pharmaceutique, département de pharmacie, CHU Sainte-Justine (CHUSJ), 3175, chemin de la Côte Sainte-Catherine, Montréal, Québec H3T 1C5, Canada
| | - D Lebel
- Unité de recherche en pratique pharmaceutique, département de pharmacie, CHU Sainte-Justine (CHUSJ), 3175, chemin de la Côte Sainte-Catherine, Montréal, Québec H3T 1C5, Canada
| | - N Marando
- Unité de recherche en pratique pharmaceutique, département de pharmacie, CHU Sainte-Justine (CHUSJ), 3175, chemin de la Côte Sainte-Catherine, Montréal, Québec H3T 1C5, Canada
| | - S Prot-Labarthe
- Département de pharmacie, hôpital Robert-Debré, AP-HP, 48, boulevard Serurier, 75019 Paris, France
| | - O Bourdon
- Département de pharmacie, hôpital Robert-Debré, AP-HP, 48, boulevard Serurier, 75019 Paris, France; Faculté de pharmacie, université Paris Descartes, 4, avenue de l'Observatoire, 75270 Paris cedex 06, France; Éducation et pratiques de santé EA 3412, université Paris Nord-13, 74, rue Marcel-Cachin, 93017 Bobigny cedex, France
| | - J-F Bussières
- Unité de recherche en pratique pharmaceutique, département de pharmacie, CHU Sainte-Justine (CHUSJ), 3175, chemin de la Côte Sainte-Catherine, Montréal, Québec H3T 1C5, Canada; Faculté de pharmacie, université de Montréal, 2900, Édouard Montpetit, Montréal, Québec H3T 1J4, Canada.
| |
Collapse
|